AI predicts who may die after hip fracture surgery
NCT ID NCT07495527
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This completed study used artificial intelligence to predict the risk of death within 30 days and 1 year after hip fracture surgery. Researchers analyzed data from 1000 patients, including age, health conditions, and lab results. The goal was to see if AI could better identify high-risk patients than traditional methods.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this AI model could help doctors better identify high-risk patients after hip fracture surgery, potentially improving care and outcomes.
What could go wrong
This is a retrospective study using existing data, so the AI may not work as well in real-world settings. It only predicts risk, not prevents death.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIP FRACTURE , POSTOPERATIVE MORTALITY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital
Ankara, 06200, Turkey (Türkiye)